Downtown Silver Spring-based United Therapeutics Corporation yesterday announced that following shareholder approval...

...it has officially converted to a public benefit corporation (PBC), the first PBC conversion of a public biotech or pharmaceutical company.

“We are inspired by our shareholders who recognize that caring for our patients, planet, employees, communities, and other stakeholders enhances our ability to generate strong shareholder returns,”...

...Martine Rothblatt, Ph.D., Chairperson and Chief Executive Officer of United Therapeutics, said in a statement.

“Becoming a PBC aligns United Therapeutics’ corporate structure with our foundational DNA and gives us a strong platform to advance our objectives of developing...

...novel pharmaceutical therapies and finding a cure for end-stage organ diseases by creating an unlimited supply of transplantable organs.”